{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,21]],"date-time":"2026-09-21T02:47:12Z","timestamp":1789958832628,"version":"4.0.1"},"reference-count":33,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2019,3,1]],"date-time":"2019-03-01T00:00:00Z","timestamp":1551398400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2019,3,1]],"date-time":"2019-03-01T00:00:00Z","timestamp":1551398400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2020,1,3]],"date-time":"2020-01-03T00:00:00Z","timestamp":1578009600000},"content-version":"am","delay-in-days":308,"URL":"http:\/\/www.elsevier.com\/open-access\/userlicense\/1.0\/"}],"funder":[{"DOI":"10.13039\/501100006364","name":"Institut National du Cancer","doi-asserted-by":"publisher","award":["INCa BCB 2013"],"award-info":[{"award-number":["INCa BCB 2013"]}],"id":[{"id":"10.13039\/501100006364","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Blood Cells, Molecules, and Diseases"],"published-print":{"date-parts":[[2019,3]]},"DOI":"10.1016\/j.bcmd.2018.12.004","type":"journal-article","created":{"date-parts":[[2018,12,20]],"date-time":"2018-12-20T03:45:11Z","timestamp":1545277511000},"page":"35-40","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":9,"special_numbering":"C","title":["WT1 gene is overexpressed in myeloproliferative neoplasms, especially in myelofibrosis"],"prefix":"10.1016","volume":"75","author":[{"given":"Laurane","family":"Cottin","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-7056-9257","authenticated-orcid":false,"given":"J\u00e9r\u00e9mie","family":"Riou","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Fran\u00e7oise","family":"Boyer","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Anne","family":"Bouvier","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alain","family":"Zannetti","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ana\u00efse","family":"Blouet","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Matgorzata","family":"Truchan-Graczyk","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"R\u00e9becca","family":"Jouanneau-Courville","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Anna\u00eblle","family":"Beucher","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"B\u00e9n\u00e9dicte","family":"Ribourtout","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Corentin","family":"Orvain","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mathilde","family":"Hunault-Berger","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Odile","family":"Blanchet","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Val\u00e9rie","family":"Ugo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Damien","family":"Luque Paz","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.bcmd.2018.12.004_bb0005","doi-asserted-by":"crossref","first-page":"2391","DOI":"10.1182\/blood-2016-03-643544","article-title":"The 2016 revision to the World Health Organization classification of myeloid neoplasms and acute leukemia","volume":"127","author":"Arber","year":"2016","journal-title":"Blood"},{"key":"10.1016\/j.bcmd.2018.12.004_bb0010","doi-asserted-by":"crossref","first-page":"2507","DOI":"10.1182\/blood-2014-05-579136","article-title":"Long-term survival and blast transformation in molecularly annotated essential thrombocythemia, polycythemia vera, and myelofibrosis","volume":"124","author":"Tefferi","year":"2014","journal-title":"Blood"},{"key":"10.1016\/j.bcmd.2018.12.004_bb0015","doi-asserted-by":"crossref","first-page":"2895","DOI":"10.1182\/blood-2008-07-170449","article-title":"New prognostic scoring system for primary myelofibrosis based on a study of the International Working Group for Myelofibrosis Research and Treatment","volume":"113","author":"Cervantes","year":"2009","journal-title":"Blood"},{"key":"10.1016\/j.bcmd.2018.12.004_bb0020","doi-asserted-by":"crossref","first-page":"1144","DOI":"10.1038\/nature03546","article-title":"A unique clonal JAK2 mutation leading to constitutive signalling causes polycythaemia vera","volume":"434","author":"James","year":"2005","journal-title":"Nature"},{"key":"10.1016\/j.bcmd.2018.12.004_bb0025","doi-asserted-by":"crossref","first-page":"2379","DOI":"10.1056\/NEJMoa1311347","article-title":"Somatic mutations of calreticulin in myeloproliferative neoplasms","volume":"369","author":"Klampfl","year":"2013","journal-title":"N. Engl. J. Med."},{"key":"10.1016\/j.bcmd.2018.12.004_bb0030","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pmed.0030270","article-title":"MPLW515L is a novel somatic activating mutation in myelofibrosis with myeloid metaplasia","volume":"3","author":"Pikman","year":"2006","journal-title":"PLoS Med."},{"key":"10.1016\/j.bcmd.2018.12.004_bb0035","doi-asserted-by":"crossref","first-page":"2391","DOI":"10.1056\/NEJMoa1312542","article-title":"Somatic CALR mutations in myeloproliferative neoplasms with nonmutated JAK2","volume":"369","author":"Nangalia","year":"2013","journal-title":"N. Engl. J. Med."},{"key":"10.1016\/j.bcmd.2018.12.004_bb0040","doi-asserted-by":"crossref","first-page":"1062","DOI":"10.1182\/blood-2014-05-578435","article-title":"Clinical effect of driver mutations of JAK2, CALR, or MPL in primary myelofibrosis","volume":"124","author":"Rumi","year":"2014","journal-title":"Blood"},{"key":"10.1016\/j.bcmd.2018.12.004_bb0045","doi-asserted-by":"crossref","first-page":"1552","DOI":"10.1182\/blood-2013-11-538983","article-title":"Impact of calreticulin mutations on clinical and hematological phenotype and outcome in essential thrombocythemia","volume":"123","author":"Rotunno","year":"2014","journal-title":"Blood"},{"key":"10.1016\/j.bcmd.2018.12.004_bb0050","doi-asserted-by":"crossref","first-page":"74","DOI":"10.1016\/j.bcmd.2016.03.003","article-title":"Clinical features of JAK2V617F- or CALR-mutated essential thrombocythemia and primary myelofibrosis","volume":"60","author":"Monte-Mor","year":"2016","journal-title":"Blood Cells Mol. Dis."},{"key":"10.1016\/j.bcmd.2018.12.004_bb0055","doi-asserted-by":"crossref","first-page":"15","DOI":"10.1042\/BJ20131587","article-title":"Mechanisms of transcriptional regulation by WT1 (Wilms' tumour 1)","volume":"461","author":"Toska","year":"2014","journal-title":"Biochem. J."},{"key":"10.1016\/j.bcmd.2018.12.004_bb0060","doi-asserted-by":"crossref","first-page":"515","DOI":"10.1016\/j.tig.2012.04.004","article-title":"The role of Wt1 in regulating mesenchyme in cancer, development, and tissue homeostasis","volume":"28","author":"Chau","year":"2012","journal-title":"Trends Genet."},{"key":"10.1016\/j.bcmd.2018.12.004_bb0065","doi-asserted-by":"crossref","first-page":"868","DOI":"10.1038\/sj.leu.2404624","article-title":"A tumor suppressor and oncogene: the WT1 story","volume":"21","author":"Yang","year":"2007","journal-title":"Leukemia"},{"key":"10.1016\/j.bcmd.2018.12.004_bb0070","doi-asserted-by":"crossref","first-page":"41","DOI":"10.1016\/j.bcmd.2012.04.001","article-title":"Expression of four major WT1 splicing variants in acute and chronic myeloid leukemia patients analyzed by newly developed four real-time RT PCRs","volume":"49","author":"Lopotov\u00e1","year":"2012","journal-title":"Blood Cells Mol. Dis."},{"key":"10.1016\/j.bcmd.2018.12.004_bb0075","doi-asserted-by":"crossref","first-page":"1841","DOI":"10.1016\/j.celrep.2014.11.004","article-title":"DNA hydroxymethylation profiling reveals that WT1 mutations result in loss of TET2 function in acute myeloid leukemia","volume":"9","author":"Rampal","year":"2014","journal-title":"Cell Rep."},{"key":"10.1016\/j.bcmd.2018.12.004_bb0080","doi-asserted-by":"crossref","first-page":"662","DOI":"10.1016\/j.molcel.2014.12.023","article-title":"WT1 recruits TET2 to regulate its target gene expression and suppress leukemia cell proliferation","volume":"57","author":"Wang","year":"2015","journal-title":"Mol. Cell"},{"key":"10.1016\/j.bcmd.2018.12.004_bb0085","doi-asserted-by":"crossref","first-page":"3071","DOI":"10.1182\/blood.V84.9.3071.3071","article-title":"WTI as a new prognostic factor and a new marker for the detection of minimal residual disease in acute leukemia","volume":"84","author":"Inoue","year":"1994","journal-title":"Blood"},{"key":"10.1016\/j.bcmd.2018.12.004_bb0090","doi-asserted-by":"crossref","first-page":"1988","DOI":"10.1200\/JCO.2003.10.503","article-title":"Piedmont study group on myleodysplastic syndromes, Significant correlation between the degree of WT1 expression and the International Prognostic Scoring System Score in patients with myelodysplastic syndromes","volume":"21","author":"Cilloni","year":"2003","journal-title":"J. Clin. Oncol. Off. J. Am. Soc. Clin. Oncol."},{"key":"10.1016\/j.bcmd.2018.12.004_bb0095","doi-asserted-by":"crossref","first-page":"2115","DOI":"10.1038\/sj.leu.2402675","article-title":"Quantitative assessment of WT1 expression by real time quantitative PCR may be a useful tool for monitoring minimal residual disease in acute leukemia patients","volume":"16","author":"Cilloni","year":"2002","journal-title":"Leukemia"},{"key":"10.1016\/j.bcmd.2018.12.004_bb0100","doi-asserted-by":"crossref","first-page":"1698","DOI":"10.1182\/blood-2002-06-1831","article-title":"The usefulness of monitoring WT1 gene transcripts for the prediction and management of relapse following allogeneic stem cell transplantation in acute type leukemia","volume":"101","author":"Ogawa","year":"2003","journal-title":"Blood"},{"key":"10.1016\/j.bcmd.2018.12.004_bb0105","doi-asserted-by":"crossref","first-page":"5195","DOI":"10.1200\/JCO.2009.22.4865","article-title":"Real-time quantitative polymerase chain reaction detection of minimal residual disease by standardized WT1 assay to enhance risk stratification in acute myeloid leukemia: a European leukemia net study","volume":"27","author":"Cilloni","year":"2009","journal-title":"J. Clin. Oncol."},{"key":"10.1016\/j.bcmd.2018.12.004_bb0110","doi-asserted-by":"crossref","first-page":"165","DOI":"10.1634\/stemcells.2006-0351","article-title":"Molecular profiling of CD34+ cells in idiopathic myelofibrosis identifies a set of disease-associated genes and reveals the clinical significance of Wilms' tumor gene 1 (WT1)","volume":"25","author":"Guglielmelli","year":"2007","journal-title":"Stem Cells"},{"key":"10.1016\/j.bcmd.2018.12.004_bb0115","doi-asserted-by":"crossref","first-page":"1650","DOI":"10.1002\/cam4.735","article-title":"The Wilms' tumor (WT1) gene expression correlates with the International Prognostic Scoring System (IPSS) score in patients with myelofibrosis and it is a marker of response to therapy","volume":"5","author":"Gallo","year":"2016","journal-title":"Cancer Med."},{"key":"10.1016\/j.bcmd.2018.12.004_bb0120","doi-asserted-by":"crossref","first-page":"378","DOI":"10.1080\/10543406.2013.860156","article-title":"Power and sample size determination in clinical trials with multiple primary continuous correlated endpoints","volume":"24","author":"Lafaye de Micheaux","year":"2014","journal-title":"J. Biopharm. Stat."},{"key":"10.1016\/j.bcmd.2018.12.004_bb0125","series-title":"Multiple Comparison Using R","author":"Bretz","year":"2016"},{"key":"10.1016\/j.bcmd.2018.12.004_bb0130","series-title":"Bioinforma. Comput. Biol. Solut. Using R Bioconductor","first-page":"249","article-title":"Multiple testing procedures: the multtest package and applications to genomics","author":"Pollard","year":"2005"},{"key":"10.1016\/j.bcmd.2018.12.004_bb0135","series-title":"Bioinformatics and Computational Biology Solutions Using R and Bioconductor","year":"2005"},{"key":"10.1016\/j.bcmd.2018.12.004_bb0140","doi-asserted-by":"crossref","first-page":"1819","DOI":"10.1007\/s00277-016-2784-x","article-title":"Circulating Cd34+ cell count differentiates primary myelofibrosis from other Philadelphia-negative myeloproliferative neoplasms: a pragmatic study","volume":"95","author":"Orvain","year":"2016","journal-title":"Ann. Hematol."},{"key":"10.1016\/j.bcmd.2018.12.004_bb0145","first-page":"7","article-title":"Clinical utility of the absolute number of circulating CD34-positive cells in patients with chronic myeloproliferative disorders","volume":"88","author":"Passamonti","year":"2003","journal-title":"Haematologica"},{"key":"10.1016\/j.bcmd.2018.12.004_bb0150","doi-asserted-by":"crossref","first-page":"203","DOI":"10.1002\/ajh.22241","article-title":"Blood tests may predict early primary myelofibrosis in patients presenting with essential thrombocythemia","volume":"87","author":"Carobbio","year":"2012","journal-title":"Am. J. Hematol."},{"key":"10.1016\/j.bcmd.2018.12.004_bb0155","doi-asserted-by":"crossref","first-page":"1960","DOI":"10.3324\/haematol.2010.026708","article-title":"Comparison of different criteria for the diagnosis of primary myelofibrosis reveals limited clinical utility for measurement of serum lactate dehydrogenase","volume":"95","author":"Beer","year":"2010","journal-title":"Haematologica"},{"key":"10.1016\/j.bcmd.2018.12.004_bb0160","doi-asserted-by":"crossref","first-page":"758","DOI":"10.1111\/j.1365-2559.2010.03545.x","article-title":"Practical application and clinical impact of the WHO histopathological criteria on bone marrow biopsy for the diagnosis of essential thrombocythemia versus prefibrotic primary myelofibrosis: bone marrow in essential thrombocythemia","volume":"56","author":"Brousseau","year":"2010","journal-title":"Histopathology"},{"key":"10.1016\/j.bcmd.2018.12.004_bb0165","doi-asserted-by":"crossref","first-page":"911","DOI":"10.1111\/bjh.12990","article-title":"WHO-histological criteria for myeloproliferative neoplasms: reproducibility, diagnostic accuracy and correlation with gene mutations and clinical outcomes","volume":"166","author":"Alvarez-Larr\u00e1n","year":"2014","journal-title":"Br. J. Haematol."}],"container-title":["Blood Cells, Molecules, and Diseases"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1079979618303474?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1079979618303474?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,21]],"date-time":"2025-10-21T12:33:44Z","timestamp":1761050024000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1079979618303474"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2019,3]]},"references-count":33,"alternative-id":["S1079979618303474"],"URL":"https:\/\/doi.org\/10.1016\/j.bcmd.2018.12.004","relation":{},"ISSN":["1079-9796"],"issn-type":[{"value":"1079-9796","type":"print"}],"subject":[],"published":{"date-parts":[[2019,3]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"WT1 gene is overexpressed in myeloproliferative neoplasms, especially in myelofibrosis","name":"articletitle","label":"Article Title"},{"value":"Blood Cells, Molecules, and Diseases","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.bcmd.2018.12.004","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2018 Elsevier Inc. All rights reserved.","name":"copyright","label":"Copyright"}]}}